The path outside the standard of care are clinical trials. The best way to get adjunct therapies tested is to start a foundation, collect money and push pre-clinical and phase 1 studies via grants.
We've definitely lost the cowboy culture that basically cured leukemia. I don't know if that is a good thing or not. Trump's new FDA law allows for some more experimentation but it's not clear it'll work.
Hopefully, the new FDA personalized precision medicine approach will allow for individual treatment that can still be aggregated into clinical trials. I think there are a lot of re-purposing experiments going on with AI/big data that should translate into preclinical work and possible new clinical trials.
We've definitely lost the cowboy culture that basically cured leukemia. I don't know if that is a good thing or not. Trump's new FDA law allows for some more experimentation but it's not clear it'll work.
Hopefully, the new FDA personalized precision medicine approach will allow for individual treatment that can still be aggregated into clinical trials. I think there are a lot of re-purposing experiments going on with AI/big data that should translate into preclinical work and possible new clinical trials.